Bifarma Adiluhung

Bifarma is the first GMP stem cell and metabolite processing plant in Indonesia. As one of the strategic business units, Bifarma Adiluhung, established in 1995, is a leading biotechnology company dedicated to providing clinically validated and quality-assured biosimilar pharmaceuticals, as well as developing innovative biopharmaceuticals that require scientific and clinical development for the global market. Bifarma Adiluhung also serves as a holding company, supporting the entire Kalbe Biopharma entity (seven subsidiaries and one research center) and acting as a new enterprise incubator for the biopharmaceutical sector. Biopharmaceuticals will play a significant role in the future of health and will become part of the world as we know it today.